Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation
Introduction: Low-grade serous ovarian cancer (LGSOC) accounting for less than 10% of all serous ovary cancers. The chemoresistance inherent to this type of ovarian cancer narrows the therapeutic options, especially in the recurrent setting. It is thought that the mitogen-activated protein kinase (...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kazimierz Wielki University
2023-08-01
|
| coleção: | Journal of Education, Health and Sport |
| Assuntos: | |
| Acesso em linha: | https://apcz.umk.pl/JEHS/article/view/44940 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|